Robert Carter - Sep 20, 2024 Form 3 Insider Report for Oncology Institute, Inc. (TOI)

Role: Chief Financial Officer
Signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Robert Ross Carter
Stock symbol: TOI
Transactions as of: Sep 20, 2024
Transactions value $: $0
Form type: 3
Date filed: 9/30/2024, 04:30 PM
Next filing: Nov 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TOI	Common Stock						4.68K	Sep 20, 2024	Direct	F1
holding	TOI	Common Stock						1.16K	Sep 20, 2024	Direct	F2
holding	TOI	Common Stock						997	Sep 20, 2024	Direct	F3
holding	TOI	Common Stock						9.57K	Sep 20, 2024	Direct	F4
holding	TOI	Common Stock						15.6K	Sep 20, 2024	Direct	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TOI	Non-Qualified Stock Option (right to buy)							Sep 20, 2024	Common Stock	11.8K	$7.09	Direct	F6
holding	TOI	Non-Qualified Stock Option (right to buy)							Sep 20, 2024	Common Stock	6.75K	$1.87	Direct	F7
holding	TOI	Non-Qualified Stock Option (right to buy)							Sep 20, 2024	Common Stock	31.9K	$0.48	Direct	F8
holding	TOI	Non-Qualified Stock Option (right to buy)							Sep 20, 2024	Common Stock	39K	$2.00	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Common Stock issued upon vesting and settlement of restricted stock units ("RSUs") prior to the reporting person's appointment as an executive officer of the Company.
F2	Represents unvested RSUs awarded to the reporting person on March 21, 2022 (the "March 2022 Grant Date"). 1/4 of the RSUs vested on the first anniversary of the March 2022 Grant Date (the "March 2022 Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each successive anniversary of the March 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F3	Represents unvested RSUs awarded to the reporting person on November 17, 2022 (the "November 2022 Grant Date"). 1/4 of the RSUs vested on the first anniversary of the November 2022 Grant Date (the "November 2022 RSU Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each anniversary of the November 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F4	Represents unvested RSUs awarded to the reporting person on March 17, 2023 (the "2023 Grant Date"). 1/4 of the RSUs vested on the first anniversary of the 2023 Grant Date (the "2023 Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each successive anniversary of the 2023 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F5	Represents unvested RSUs awarded to the reporting person on May 21, 2024 (the "2024 Grant Date"). 1/4 of the RSUs will vest on the first anniversary of the 2024 Grant Date (the "2024 Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each successive anniversary of the 2024 RSU Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F6	The stock options vest as to 1/4 of the options granted on the March 2022 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the March 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F7	The stock options vest as to 1/4 of the options granted on the November 2022 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the November 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F8	The stock options vest as to 1/4 of the options granted on the 2023 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the 2023 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F9	The stock options vest as to 1/4 of the options granted on the 2024 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the 2024 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.

Remarks:

**Exhibit List: Exhibit 24 - Power of Attorney